ATC Group: B01AC06 Acetylsalicylic acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B01AC06 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B01 Antithrombotic agents
3 B01A Antithrombotic agents
4 B01AC Platelet aggregation inhibitors excl. heparin
5 B01AC06 Acetylsalicylic acid

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 1 {dose}

Active ingredients in B01AC06

Active Ingredient

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.

Related product monographs

Document Type Information Source  
 ASA Delayed-release tablet MPI, CA: SPM Health Products and Food Branch (CA)
 CAPRIN Gastro-resistant tablet MPI, EU: SmPC Health Products Regulatory Authority (IE)
 NU-SEALS Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines in this ATC group

Canada (CA)

Croatia (HR)

Cyprus (CY)

Finland (FI)

Hong Kong (HK)

Ireland (IE)

Italy (IT)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Nigeria (NG)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.